Therefore, although NFkB activation in MM tumors results mainly from extrinsic signaling (Fig. 2 and above), the mutations that occur during progression and that constitutively activate NFkB would be expected to decrease dependence of tumor cells on the BM microenvironment (Fig.3). Here, NFKB1 is linked to Miyoshi myopathy.